Ticker > Company >

Kronox Lab Sciences share price

Kronox Lab Sciences Ltd.

  45.46 K   53   10 NSE: KRONOX BSE: 544187 SECTOR: Chemicals

184.69
+1.32 (0.72%)
NSE: 04 Sep 4:00 PM

Price Summary

Today's High

₹ 189

Today's Low

₹ 182

52 Week High

₹ 223.42

52 Week Low

₹ 96

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyExcellent
The company knows very well the utilization of its assets.
FinancialsAverage
The company could improve upon its asset employment.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

685.27 Cr.

Enterprise Value

638.14 Cr.

No. of Shares

3.71 Cr.

P/E

23.99

P/B

5.55

Face Value

₹ 10

Div. Yield

0.27 %

Book Value (TTM)

₹  33.27

CASH

48.74 Cr.

DEBT

1.61 Cr.

Promoter Holding

74.21 %

EPS (TTM)

₹  7.7

Sales Growth

1.02%

ROE

26.82 %

ROCE

36%

Profit Growth

8.61 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year1.02%
3 Year1.93%
5 Year10.14%

Profit Growth

1 Year8.61%
3 Year19.03%
5 Year23.24%

ROE%

1 Year26.82%
3 Year32.61%
5 Year35.39%

ROCE %

1 Year36%
3 Year43.78%
5 Year47.66%

Debt/Equity

0.0138

Price to Cash Flow

28.68

Interest Cover Ratio

328.2105

CFO/PAT (5 Yr. Avg.)

0.963452733509715

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Jun 2026 74.21 0.00
Mar 2026 74.21 0.00
Dec 2025 74.21 0.00
Sep 2025 74.21 0.00
Jun 2025 74.21 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good profit growth of 19.0258244974251% for the Past 3 years.
  • Company has been maintaining healthy ROE of 32.6133666666667% over the past 3 years.
  • Company has been maintaining healthy ROCE of 43.7823333333333% over the past 3 years.
  • Company is virtually debt free.
  • Company has a healthy Interest coverage ratio of 328.2105.
  • The Company has been maintaining an effective average operating margins of 29.0187% in the last 5 years.
  • The company has an efficient Cash Conversion Cycle of 46.3345 days.
  • Company has a healthy liquidity position with current ratio of 7.6046.
  • The company has a high promoter holding of 74.21%.

 Limitations

  • The company has shown a poor revenue growth of 1.93019770622997% for the Past 3 years.

Quarterly Result (All Figures in Cr.)

PARTICULARS Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
Net Sales 24.29 25.53 25.27 26.13 28.39
Total Expenditure 16.32 16.89 17.25 16.61 19.39
Operating Profit 7.97 8.65 8.02 9.52 9
Other Income 0.87 1.04 1.13 2.15 1.3
Interest 0 0.04 0.04 0.04 0.03
Depreciation 0.4 0.47 0.52 0.66 0.45
Exceptional Items 0 0 0 0 0
Profit Before Tax 8.44 9.18 8.6 10.97 9.81
Tax 2.16 2.5 2.01 2.97 2.51
Profit After Tax 6.28 6.68 6.59 8 7.3
Adjusted EPS (Rs) 1.69 1.8 1.78 2.16 1.97

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Net Sales 82.25 95.58 89.86 100.19 101.22
Total Expenditure 62.55 73.87 61.55 67.07 66.95
Operating Profit 19.7 21.71 28.32 33.13 34.27
Other Income 1.09 1.92 1.58 2.53 5.19
Interest 0.41 0.09 0 0 0.11
Depreciation 2.03 1.5 1.29 1.38 2.05
Exceptional Items 0 0 0 0 0
Profit Before Tax 18.36 22.04 28.61 34.27 37.3
Tax 4.73 5.64 7.26 8.8 9.64
Net Profit 13.63 16.4 21.35 25.47 27.66
Adjusted EPS (Rs.) 3.49 4.42 5.75 6.86 7.45

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity and Liabilities
Share Capital 0.24 37.1 37.1 37.1 37.1
Total Reserves 40.11 7.65 29.2 53 79.02
Borrowings 0.47 0 0 0 1
Other N/C liabilities 1.87 0.15 -0.36 -0.37 -0.38
Current liabilities 13.76 9.01 7.67 8.7 10.37
Total Liabilities 56.46 53.9 73.61 98.43 127.12
Assets
Net Block 11.3 15.91 26.41 27.86 28.73
Capital WIP 0 0 0.49 0.76 0.88
Intangible WIP 0 0 0 0 0
Investments 0.03 0.03 0.03 0.03 0.03
Loans & Advances 0.98 0.07 0.1 0.1 0.1
Other N/C Assets 0 3.5 0 6.38 18.54
Current Assets 44.16 34.39 46.6 63.31 78.84
Total Assets 56.46 53.9 73.61 98.43 127.12
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Profit from operations 18.36 22.04 28.61 34.27 37.3
Adjustment 2.33 1.18 0.54 -0.13 -1.29
Changes in Assets & Liabilities -6.88 2.17 -4.38 5.44 -2.4
Tax Paid -4.79 -5.72 -7.35 -8.88 -9.72
Operating Cash Flow 9.02 19.66 17.42 30.7 23.89
Investing Cash Flow -7.6 -6.6 -17.31 -28.39 -23.82
Financing Cash Flow -0.67 -13.4 0 -1.85 -0.36
Net Cash Flow 0.76 -0.33 0.1 0.45 -0.29

Corporate Actions

Investors Details

PARTICULARS Jun 2025% Sep 2025% Dec 2025% Mar 2026% Jun 2026%
promoters 74.21 74.21 74.21 74.21 74.21
jogindersingh g jaswal 26.39 26.39 26.39 26.39 26.39
ketan vinodchandra ramani... 26.39 26.39 26.39 26.39 26.39
ramani pritesh v 21.40 21.40 21.40 21.40 21.40
PARTICULARS Jun 2025% Sep 2025% Dec 2025% Mar 2026% Jun 2026%
investors 25.79 25.79 25.79 25.79 25.79
negen undiscovered value ... 1.71 1.71 1.71 1.71 1.71

Annual Reports

Title Link
Title Link
Annual Report 2025
Annual Report 2024

Ratings & Research Reports

TYPE AGENCY Link
TYPE AGENCY Link
 No Credit reports exist for this company.Report us
TYPE AGENCY Link
TYPE AGENCY Link
 No Research reports exist for this company.Report us

Concalls & Presentations

TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Concall related to this company.Report us
TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Presentation related to this company.Report us

Company News

Kronox Lab Sciences informs about disclosure 21 Aug, 9:39 AM Kronox Lab Sciences - Quaterly Results 11 Aug, 5:36 PM Kronox Lab Sciences - Quaterly Results 11 Aug, 5:36 PM Kronox Lab Sciences - Quaterly Results 11 Aug, 5:36 PM Kronox Lab Sciences informs about press release 28 Jul, 3:47 PM Kronox Lab Sciences informs about AGM 26 Jul, 4:12 PM Kronox Lab Sciences informs about appointment of secretarial audior 26 Jul, 3:12 PM Kronox Lab Sciences informs about financial results 22 May, 5:33 PM Kronox Lab Sciences - Quaterly Results 22 May, 5:27 PM Kronox Lab Sciences - Quaterly Results 22 May, 5:27 PM Kronox Lab Sciences - Quaterly Results 22 May, 5:27 PM Kronox Lab Sciences informs about disclosure 5 May, 5:15 PM KRONOX Lab Sciences informs about integrated filing 6 Feb, 2:37 PM Kronox Lab Sciences informs about integrated filing 6 Feb, 1:09 PM Kronox Lab Sciences informs about disclosure 1 Feb, 10:14 AM Kronox Lab Sciences - Quaterly Results 31 Jan, 4:53 PM Kronox Lab Sciences - Quaterly Results 31 Jan, 4:53 PM Kronox Lab Sciences - Quaterly Results 31 Jan, 4:53 PM Kronox Lab Sciences informs about board meeting 23 Jan, 5:07 PM Kronox Lab Sciences informs about closure of trading window 27 Dec, 11:25 AM Kronox Lab Sciences - Quaterly Results 15 Nov, 5:54 PM Kronox Lab Sciences - Quaterly Results 15 Nov, 5:54 PM Kronox Lab Sciences - Quaterly Results 15 Nov, 5:54 PM Kronox Lab gets provisional consent for setting up Industrial Plant at Dahej 14 Nov, 2:12 PM Kronox Lab Sciences informs about compliance certificate 10 Oct, 4:48 PM KRONOX Lab Sciences informs about AGM and annual report 8 Aug, 4:54 PM Kronox Lab Sciences - Quaterly Results 6 Aug, 1:00 PM Kronox Lab Sciences - Quaterly Results 6 Aug, 1:00 PM Kronox Lab Sciences - Quaterly Results 6 Aug, 1:00 PM Kronox Lab Sciences - Quaterly Results 28 Jun, 5:39 PM Kronox Lab Sciences - Quaterly Results 28 Jun, 5:39 PM Kronox Lab Sciences - Quaterly Results 28 Jun, 5:39 PM KRONOX Lab Sciences informs about board meeting 20 Jun, 5:17 PM

Kronox Lab Sciences Stock Price Analysis and Quick Research Report. Is Kronox Lab Sciences an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Kronox Lab Sciences. 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Kronox Lab Sciences has a PE ratio of 23.9866488304739 which is high and comparatively overvalued.

  • Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Kronox Lab Sciences has ROA of 24.5268% which is a good sign for future performance. (Higher values are always desirable.)

  • Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Kronox Lab Sciences has a Current ratio of 7.6046.

  • Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Kronox Lab Sciences has a ROE of 26.8242%. (Higher is better)

  • Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Kronox Lab Sciences has a Debt to Equity ratio of 0.0138 which means that the company has low proportion of debt in its capital.

  • Sales growth: Kronox Lab Sciences has reported revenue growth of 1.024% which is poor in relation to its growth and performance. 

  • Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Kronox Lab Sciences for the current financial year is 33.8569452677336%.

  • Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Kronox Lab Sciences is Rs 0.5 and the yield is 0.2715%.

  • Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Kronox Lab Sciences is Rs 7.6997. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Kronox Lab Sciences in Ticker for free. Also, one can get the intrinsic value of Kronox Lab Sciences by using Valuation Calculators, which are available with a Finology ONE subscription. 

Kronox Lab Sciences FAQs

Q1. What is Kronox Lab Sciences share price today?
Ans: The current share price of Kronox Lab Sciences is Rs 184.69.

Q2. What is the market capitalisation of Kronox Lab Sciences?
Ans: Kronox Lab Sciences has a market capitalisation of Rs 685.273776 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Kronox Lab Sciences?
Ans: The PE ratio of Kronox Lab Sciences is 23.9866488304739 and the P/B ratio of Kronox Lab Sciences is 5.55191486803343, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Kronox Lab Sciences share?
Ans: The 52-week high share price of Kronox Lab Sciences is Rs 223.42, and the 52-week low share price of Kronox Lab Sciences is Rs 96.

Q5. Does Kronox Lab Sciences pay dividends?
Ans: Currently, Kronox Lab Sciences pays dividends. Dividend yield of Kronox Lab Sciences is around 0.2715%.

Q6. What are the face value and book value of Kronox Lab Sciences shares?
Ans: The face value of Kronox Lab Sciences shares is Rs 10, while the book value per share of Kronox Lab Sciences is around Rs 33.266. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Kronox Lab Sciences?
Ans: Kronox Lab Sciences has a total debt of Rs 1.607 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Kronox Lab Sciences?
Ans: The ROE of Kronox Lab Sciences is 26.8242% and ROCE of Kronox Lab Sciences is 36.0048%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Kronox Lab Sciences a good buy for the long term?
Ans: The Kronox Lab Sciences long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Kronox Lab Sciences undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Kronox Lab Sciences appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Kronox Lab Sciences’s financials?
Ans: You can review Kronox Lab Sciences’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.

Last Updated on:
Brief about Kronox Lab Sciences
X